12th International Congress on Myeloproliferative Neoplasms
Update on Myeloid Variant Hypereosinophilia Syndrome: Clinical Subtype is Important Predictor of Therapy Response, Targeted Therapies Changed Approach to HES
Login to view comments.
Click here to Login